Gastric Cancer
| Editor: | Jiafu Ji |
Publisher: AME Publishing Company; 1st edition (2015)
ISBN-13: 978-9881299765
Hardcover: 408 pages
Language: English
Available at: 
This edition on "Gastric Cancer" which has been edited by Professor Jiafu Ji covers topics on the diagnosis, multidisciplinary approach, surgical research, chemotherapy, targeted therapy, radiation therapy, and translational research. In addition, there is a novel section which includes 35 surgical video articles in the book. This book will be a great resource and update on the cutting-edge advances made in the diagnostic approaches and treatment modalities available to clinicians.
Editors
| Jiafu Ji | Department of Gastrointestinal Surgery, Beijing Cancer Hospital and Institute, Peking University School of Oncology, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China |
Associate Editors
| Hyung-Ho Kim | Department of Surgery, Seoul National University College of Medicine, Seoul, Korea; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea |
| Guy D. Eslick | The Whiteley-Martin Research Centre, Discipline of Surgery, The Sydney Medical School Nepean, Penrith, New South Wales, Australia |
Assistant Editors
| Sang-Hoon Ahn | Department of Surgery, Seoul National University College of Medicine, Seoul, Korea; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea |
| Zhaode Bu | Department of Gastrointestinal Surgery, Beijing Cancer Hospital and Institute, Peking University School of Oncology, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China |
Table of Contents
Foreword
Preface
2 Controversies in the diagnosis and management of early gastric cancer
Editorial
6 Multidisciplinary approach for the treatment of gastric cancer
9 A current view of gastric cancer in China
13 Management of gastric cancer: the Chinese perspective
18 The first step on earth: a small step for a trial, a giant leap for mankind
20 Can the ARTISTs complete the Schubert Unfinished (Sinfonie Nr. 7 in h moll D. 759 “Die Unvollendete”)?
22 Treatment strategies in node-negative gastric cancer
Diagnosis
25 Gastric cancer: classification, histology and application of molecular pathology
36 FDG PET imaging in the staging and management of gastric cancer
42 Lymph node staging in gastric remnant carcinoma
44 The role of 18FDG-PET in gastric cancer
47 Aberrant DNA methylation as sensitive and promising biomarkers in diagnosing of cancers
50 Adenocarcinoma of esophagogastric junction requires a clearer definition
Multidisciplinary Approach
55 Updating advances and controversies on the multidisciplinary therapy of gastric cancer
65 Multidisciplinary approach for the treatment of gastric cancer
68 Gastric metastasis of Merkel cell carcinoma, a rare cause of gastrointestinal bleeding: case report and review of the literature
73 Self-expandable metallic stent placement for palliation in gastric outlet obstruction
Surgical Research
84 Training as a surgeon: not just knowledge and skills
86 Single-incision laparoscopic distal gastrectomy for early gastric cancer
90 Mid-term results after single incision transumbilical laparoscopic sleeve gastrectomy
96 Laparoscopy-assisted gastrectomy following neoadjuvant chemotherapy for advanced gastric cancer - strategies for development
103 Laparoscopic D2 dissection for locally advanced gastric cancer in China
105 Perfect-results after laparoscopic surgery for gastroesophageal reflux - are they achievable?
111 Future perspective of laparoscopic surgery for gastric cancer: sentinel node navigation functionpreserving surgery for early gastric cancer
115 Rationale of oncological follow-up after gastrectomy for cancer—the Consensus Conference
117 Laparoscopic total gastrectomy with spleen-preserving splenic hilar (No. 10) lymph node dissection for gastric cancer is still a challenging procedure
119 Totally laparoscopic stapled anastomosis after distal gastrectomy
121 Safe, simple & efficient totally laparoscopic Billroth II gastrectomy by only stapling devices
125 What is the best reconstruction after totally laparoscopic distal gastrectomy if the delta-shaped gastroduodenostomy cannot be performed?
127 Node-negative gastric cancer: a good occasion for studying new prognostic factors
129 Completely laparoscopic reconstruction following distal gastrectomy: what is the best method?
132 Emergency surgery for perforated gastric malignancy: an institution’s experience and review of the literature
138 Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials
Surgical Video
145 Intracorporeal laparoscopic esophagojejunostomy using endoscopic linear staplers: the experiences of 293 cases
149 Reducing the number of abdominal ports used for laparoscopic distal gastrectomy using the “MiniLap” grasper
151 Functional end-to end esophago-jejunal anastomosis using linear staplers following laparoscopic total gastrectomy
153 Laparoscopic total gastrectomy with spleen-preserving splenic hilar (No. 10) lymph nodes dissection
156 Standard lymph node dissection (D2 surgery) for antral carcinoma
159 Laparoscopic spleen-preserving splenic hilar lymph node dissection for proximal gastric cancer
161 Radical proximal gastrectomy with modified double tracks anastomosis after preoperative chemotherapy for gastric cancer
164 Totally laparoscopic distal gastrectomy reconstructed by Rouxen-Y with D2 lymphadenectomy and needle catheter jejunostomy for gastric cancer
169 Laparoscopy-assisted D2 radical distal gastrectomy
171 Laparoscopic assistant distal radical gastrectomy
173 D2 distal subtotal gastrectomy for antral carcinoma
176 Laparoscopy-assisted radical total gastrectomy plus D2 lymph node dissection
182 Laparoscopy-assisted radical total gastrectomy plus D2 lymph node dissection/dissection of lymph node station 16
186 A case of laparoscopy-assisted radical distal gastrectomy
189 Laparoscopy-assisted D2 gastrectomy plus laparoscopic bursectomy in locally advanced gastric cancer patients
192 Radical total gastrectomy plus D2 dissection for gastric cancer
193 Radical surgery for cardia carcinoma: total gastrectomy, D2 + No.10 dissection, esophagojejunal Rouxen-Y anastomosis
200 D2 surgery for a gastric cancer patient after neoadjuvant chemotherapy
202 Laparoscopy-assisted D2 radical distal subtotal gastrectomy
208 Radical proximal gastrectomy for gastric carcinoma
212 Laparoscopic D2 dissection for gastric cancer
216 Anatomy of laparoscopy-assisted distal D2 radical gastrectomy for gastric cancer
223 Laparoscopic radical gastrectomy for gastric cancer
236 Laparoscopy-assisted D2 radical distal gastrectomy for gastric cancer (Billroth II anastomosis)
238 Laparoscopic gastrectomy for distal gastric cancer
240 Total laparoscopic-assisted radical gastrectomy (D2+) with jejunal Roux-en-Y reconstruction
242 Pylorus- and vagus-nerve-preserving partial gastrectomy (D2 dissection)
245 Laparoscopic-assisted radical gastrectomy for distal gastric cancer
248 Delta-shaped anastomosis in totally laparoscopic D2 radical distal gastrectomy
250 Station 10 lymph node dissections in laparoscopic-assisted spleenpreserving radical gastrectomy for advanced proximal gastric cancer
253 Radical gastrectomy for D2 distal gastric cancer
256 Curettage and aspiration in splenic hilar lymph node dissection for spleen-preserving radical D2 gastrectomy
259 Laparoscopic distal gastrectomy with D2 dissection for advanced gastric cancer
262 Spleen-preserving splenic lymph node dissection in radical total gastrectomy
264 D2 plus radical resection combined with perioperative chemotherapy for advanced gastric cancer with pyloric obstruction
Chemotherapy
267 Neoadjuvant chemotherapy for gastric cancer
270 Gastric cancer: toward a cisplatin-free disease?
275 The role of taxanes in the management of gastroesphageal cancer
286 A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma
Targeted Therapy
294 Targeting angiogenesis in advanced gastric cancer: is this end of the road?
297 Costs of trastuzumab in combination with chemotherapy for HER2-positive advanced gastric or gastroesophageal junction cancer: does one “Analysis” fit all?
300 Pharmacoeconomic studies of targeted agents in gastric cancer: ready for prime time?
303 A case report of trastuzumab dose in gastric cancer
307 Long-term survival in an advanced gastric cancer patient treated with cetuximab in association with FOLFIRI: a case report
312 Genetics and molecular pathology of gastric malignancy: Development of targeted therapies in the era of personalized medicine
320 Molecular therapy for gastric cancer
Radiation Therapy
328 Palliative radiation therapy for primary gastric melanoma
Translational Research
333 Research on microRNAs leads to new frontiers of clinical and translational relevance for gastric cancer management
339 Clinical and molecular aspects of miR-200 family in gastric cancer
342 ADAM and EMMPRIN: a promising couple for more prognostic precision in patients with gastric cancer
345 Evaluation of JWA and XRCC1 expressions in gastric cancer
349 Re: Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer by Xu et al.
351 The usefulness of CDH1 methylation as a gastric cancer peritoneal metastasis biomarker
354 Fatal attraction: tumor recruitment of myeloid-derived suppressor cells is mediated by IL-17-producing CD8+ T cells
358 Optimal lymphadenectomy for gastric cancer: is there a magic number?
361 Survival of metastatic gastric cancer: significance of age, sex and race/ethnicity
370 Gastric cancer—a clinicopathological study in a tertiary care centre of North-eastern India
Click the book to view the entire PDF
